1,757 drugs from the clinical trials of the companies BioRadar tracks, 404 of them FDA-approved. Each page shows what the drug is, what it targets, who develops it, how far it has come and its trials, from FDA, NIH and ClinicalTrials.gov data.
Data: FDA, NIH and ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All tracked stocks A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.